Christopher B. Ehrlich - 26 Sep 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role
Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Christopher B. Ehrlich
Issuer symbol
EFTR on OTC
Transactions as of
26 Sep 2022
Net transactions value
+$10,377
Form type
4
Filing time
27 Sep 2022, 08:01:27 UTC
Previous filing
13 Jun 2022
Next filing
06 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Purchase $10,377 +18,867 +118% $0.5500 34,867 26 Sep 2022 Direct
holding EFTR Common Stock 142,168 26 Sep 2022 By Locust Walk Partners LLC F1
holding EFTR Common Stock 1,034 26 Sep 2022 By Locust Walk Partners LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person.
F2 Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse.